Dr. Todd Johnson Joins MDS Pharma Services as Senior Vice-President for Strategy and Corporate Development
31 Mai 2007 - 3:05PM
PR Newswire (US)
KING OF PRUSSIA, PA, May 31 /PRNewswire-FirstCall/ -- MDS Pharma
Services, a leading provider of innovative drug discovery and
development solutions, has named Dr. Todd Johnson to the position
of Senior Vice-President for Strategy and Corporate Development.
Dr. Johnson will lead efforts to accelerate profitable growth
through strategic partnerships and acquisitions. Before joining
MDS, Dr. Johnson spent five years at McKinsey & Company, where
he led strategic consulting engagements at several major
pharmaceutical and biotech firms. Prior to that, he was CEO of
Tangerine Technologies, a biotech software firm he founded in 1997.
He started his career as a Cancer Biologist, conducting biomedical
research at Harvard University's Dana-Farber Cancer Institute in
Boston, the University of Pennsylvania in Philadelphia, and the
National Institutes of Health in Bethesda. "I am excited that Dr.
Johnson has joined the MDS Pharma Services team to help drive our
growth efforts," said MDS Pharma Services President David Spaight.
"His expertise in medical research and consulting will help us to
leverage industry trends to develop new services for our clients."
Educated at the University of Pennsylvania in Philadelphia, Dr.
Johnson holds an MBA from its Wharton School, an MD from its
Medical School, and a BA in Neurobiology from its College of Arts
and Sciences' honors program. During his college career, he also
studied Philosophy and Cognitive Neuroscience at St. Catherine's
College of Oxford University in the United Kingdom. About MDS
Pharma Services MDS Pharma Services offers a full spectrum of
resources to meet the drug discovery and development needs of the
pharmaceutical and biotechnology industries. With numerous
facilities strategically located around the world, we apply
advanced scientific and technological expertise throughout the drug
discovery and development process - from lead optimization, pre-IND
research, early clinical research (bioequivalence, phases I-IIa)
and bioanalysis through to global clinical development (phases
IIb-IV), central lab and centralized cardiac services. For more
information, visit our website at http://www.mdsps.ccom/. MDS
Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE:
MDZ), a global life sciences company that provides market-leading
products and services that our customers need for the development
of drugs and diagnosis and treatment of disease. We are a leading
global provider of pharmaceutical contract research, medical
isotopes for molecular imaging, radiotherapeutics, and analytical
instruments. MDS has more than 6,200 highly skilled people in 28
countries. Find out more at http://www.mdsinc.com/ or by calling
1-888-MDS-7222, 24 hours a day. DATASOURCE: MDS Pharma Services
CONTACT: For Investors: Sharon Mathers, (416) 675-6777 ext. 34721,
; For Media: Charlene McGrady, (610) 239-7900 ext. 231,
Copyright